Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose‐finding, randomized, double‐blind, placebo‐controlled trial for Alzheimer's disease
Hsien‐Yuan Lane, Shi‐Heng Wang, Chieh‐Hsin Lin
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 2, pp. 102-109
Open Access | Times Cited: 17

Showing 17 citing articles:

d-Amino acids: new clinical pathways for brain diseases
Isis N. O. Souza, Robin Roychaudhuri, Jacqueline de Belleroche, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 12, pp. 1014-1028
Open Access | Times Cited: 26
Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
Letizia Biso, Marco Carli, Marco Scarselli, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 85-85
Open Access | Times Cited: 1
Food additives for the central nervous system, useful or harmful? An evidence-based review
Mohammadmahdi Fadaei, Amirhossein Sangi Nasab Lahijan, Davood Jahanmehr, et al.
Nutritional Neuroscience (2025), pp. 1-18
Closed Access
Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
ARMAN YURISALDI SALEH, Dwi Arwandi Yogi Saputra, Riezky Valentina, et al.
F1000Research (2025) Vol. 14, pp. 275-275
Open Access
Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: Secondary analysis of a randomized clinical trial of benzoate
Chieh‐Hsin Lin, Shi‐Heng Wang, Hsien‐Yuan Lane
Psychiatry and Clinical Neurosciences (2025)
Closed Access
Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline
Hsien‐Yuan Lane, Shi‐Heng Wang, Chieh‐Hsin Lin
Psychiatry Research (2023) Vol. 326, pp. 115288-115288
Closed Access | Times Cited: 7
Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients
Chieh‐Hsin Lin, Tin‐May Li, Yu-Jhen Huang, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 8, pp. 576-583
Open Access | Times Cited: 7
Physical Compatibility of Reduced Glutathione for Injection With 44 Intravenous Drugs During Simulated Y-site Administration
Rui Wu, Gaochao Zhu, Yinghui Ju, et al.
Clinical Therapeutics (2024)
Closed Access | Times Cited: 2
Sodium benzoate: A novel multi-target pharmaceutical approach to rescue clozapine-resistant schizophrenia
Chieh‐Hsin Lin, Hsien‐Yuan Lane
Schizophrenia Research (2023)
Closed Access | Times Cited: 5
Sex- and dose-dependent catalase increase and its clinical impact in a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease
Hsien‐Yuan Lane, Shi‐Heng Wang, Chieh‐Hsin Lin
Pharmacology Biochemistry and Behavior (2024) Vol. 245, pp. 173885-173885
Closed Access | Times Cited: 1
Mapping new pharmacological interventions for cognitive function in Alzheimer’s disease: a systematic review of randomized clinical trials
Inmaculada Xu Lou, Jiayue Chen, Kamran Ali, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Elucidating the Mechanisms of Sodium Benzoate in Alzheimer Disease: Insights from Quantitative Proteomics Analysis of Serum Samples
Chieh‐Hsin Lin, Hsin-Yi Liao, Hsien‐Yuan Lane, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 12, pp. 856-866
Open Access | Times Cited: 4
Intra-uterus phthalate exposure, ROS formation and altered mitochondrial D-loop methylation pattern at birth as potential triggers and markers of Alzheimer’s disease
Eduarda Colbeich da Silveira, José Artur Bogo Chies
Medical Hypotheses (2024) Vol. 187, pp. 111355-111355
Closed Access | Times Cited: 1
Adjunctive transcranial direct current stimulation (tDCS) plus sodium benzoate for the treatment of early-phase Alzheimer's disease: A randomized, double-blind, placebo-controlled trial
Hsien‐Yuan Lane, Shi‐Heng Wang, Chieh‐Hsin Lin
Psychiatry Research (2023) Vol. 328, pp. 115461-115461
Closed Access | Times Cited: 2
Effects of sodium benzoate on cognitive function in neuropsychiatric disorders: a systematic review and meta-analysis
Chun-Wei Liang, Hsiao-Yi Cheng, Mei‐Chih Meg Tseng
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Safety and efficacy of sodium benzoate for patients with mild Alzheimer’s disease: a systematic review and meta-analysis
Mohamed Ezzat M. Mansour, Ahmed Hamdy G. Ali, Mohamed Ibrahim, et al.
Nutritional Neuroscience (2024), pp. 1-10
Closed Access
Upregulation of serotonin by sodium benzoate and sodium metabisulfite may activate caloric restriction which could enhance longevity and cognition
John Sylvester Nas, Paul Mark B. Medina
Medical Hypotheses (2023) Vol. 178, pp. 111120-111120
Open Access
Page 1

Scroll to top